Dr Reddys Laboratories RDY
NYSE RDY
$12.18 +0.07 (+0.58%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dr Reddys Laboratories (RDY) Assets Growth (3y) (2021 - 2026)

Dr Reddys Laboratories (RDY) Assets Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.39%
Mar 31, 2025 14.35%
Mar 31, 2024 8.60%
Mar 31, 2023 8.32%
Mar 31, 2022 5.80%
Mar 31, 2021 1.56%